PDE 10 inhibitors (Amgen/Memory)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NamePDE 10 inhibitors (Amgen/Memory)
Drug Alias NamePDE 10A inhibitors (Memory)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodiesterase 10A inhibitors
TargetsPhosphodiesterase 10A
Therapy Area/IndicationsMental DisordersNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMemory Pharmaceuticals Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsMental DisordersNervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A